Clinical Trial of BMS-986504 in Recurrent GBM Patients
NCT06883747
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma WHO Grade IV
Interventions
DRUG:
BMS-986504
Sponsor
Nader Sanai